John Theurer Cancer Center (JTCC), at Hackensack Meridian Health Hackensack University Medical Center in New Jersey, and Genomic Testing Cooperative (GTC), Irvine, CA, announced today an agreement to establish a state-of-the-art, next...
Read More »Tempus launches new RNA sequencing-based oncology test for precision medicine
Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, announced the launch of...
Read More »CICERO – a versatile method for detecting complex and diverse driver fusions using cancer RNA sequencing data
To discover driver fusions beyond canonical exon-to-exon chimeric transcripts, researchers at St. Jude Children’s Research Hospital have developed CICERO, a local assembly-based algorithm that integrates...
Read More »A novel prognostic two-gene signature for triple negative breast cancer
The absence of a robust risk stratification tool for triple negative breast cancer (TNBC) underlies imprecise and nonselective treatment of these...
Read More »Bayer and Neogenomics to provide RNA sequencing-based testing for NTRK gene fusion at no cost for people living with advanced thyroid and colorectal cancers
Bayer today announced the launch of Test4TRK™ program in collaboration with NeoGenomics, Inc. to offer genomic cancer testing for NTRK gene fusions at no cost for patients with RAI-refractory (RAI-R) differentiated thyroid carcinoma (DTC) and metastatic...
Read More »RNA Sequencing uncovers diagnostic biomarkers for rare kidney cancer
U-M study combines local data with data from The Cancer Genome Atlas to discover novel biomarkers for chromophobe renal cell carcinoma through...
Read More »Transcriptome analysis can help identify cancer patients most likely to develop cachexia
Researchers in Brazil analyzed 12 types of tumor and established a gene expression profile associated with cachexia, a potentially fatal syndrome characterized by severe weight loss and muscle wasting. It is estimated that as many as 80% of advanced-stage cancer ...
Read More »Long noncoding RNAs in cancer – from discovery to therapeutic targets
Long noncoding RNAs (lncRNAs) have recently gained considerable attention as key players in biological regulation; however, the mechanisms by...
Read More »Study shows single-cell RNA sequencing can be used on solid tumor liquid biopsy
Small cell lung cancer (SCLC) accounts for 14% of all lung cancers and is often rapidly resistant to chemotherapy, resulting in poor clinical outcomes...
Read More »Algorithms for identifying new “cancer genes”
It is estimated that the number of cancer cases worldwide will double by 2040. This makes the search for genes that cause cancer even more important. A team of researchers from the...
Read More »